These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7699837)

  • 1. [In vitro antifungal activities of lanoconazole against stock cultures and clinical isolates of Candida albicans].
    Niwano Y; Ohmi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1995 Jan; 48(1):140-5. PubMed ID: 7699837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the in vitro antifungal activity of lanoconazole, a new topical antimycotic, against Trichophyton spp].
    Niwano Y; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1995 Jan; 48(1):146-9. PubMed ID: 7699838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of lysozyme and lanoconazole on the morphology of Candida albicans.
    Nishiyama Y; Nakaoka C; Hiratani T; Abe S; Uchida K; Yamaguchi H
    J Electron Microsc (Tokyo); 2001; 50(1):41-9. PubMed ID: 11291959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives.
    Lukaszuk C; Krajewska-Kułak E; Niewiadomy A; Stachowicz J; Głaszcz U; Oksiejczuk E
    Adv Med Sci; 2007; 52 Suppl 1():26-9. PubMed ID: 18229628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Various factors influencing in vitro antifungal activities of omoconazole nitrate (OMZ), a new imidazole antimycotic].
    Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1994 Jan; 47(1):40-9. PubMed ID: 8114272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait.
    Alfouzan W; Dhar R; Ashkanani H; Gupta M; Rachel C; Khan ZU
    J Mycol Med; 2015 Mar; 25(1):23-8. PubMed ID: 25534676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
    Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
    Vardar-Unlu G; Yağmuroğlu A; Unlu M
    Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some 1-(2,4-dihydroxythiobenzoyl)imidazoles, -imidazolines and -tetrazoles and their potent activity against Candida species.
    Matysiak J; Niewiadomy A; Krajewska-Kułak E; Macik-Niewiadomy G
    Farmaco; 2003 Jun; 58(6):455-61. PubMed ID: 12767386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antifungal activity of omoconazole nitrate, a new imidazole antimycotic].
    Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1993 Sep; 46(9):773-80. PubMed ID: 8254897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent.
    Uchida K; Nishiyama Y; Yamaguchi H
    J Infect Chemother; 2004 Aug; 10(4):216-9. PubMed ID: 15365862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antifungal activity of omoconazole nitrate, a novel imidazone antimycotic drug, against clinical isolates from patients with cutaneous mycosis].
    Uchida K; Itoyama T; Yamaguchi H
    Jpn J Antibiot; 1996 Aug; 49(8):818-23. PubMed ID: 9053537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species.
    Uchida K; Nishiyama Y; Tanaka T; Yamaguchi H
    Int J Antimicrob Agents; 2003 Mar; 21(3):234-8. PubMed ID: 12636984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.